complete remission of nephrotic syndrome and acute kidney injury in crescentic iga nephropathy: role of mycophenolate sodium
Clicks: 301
ID: 167268
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
301 views
48 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #6 of 47 articles by views in journal of the chemical society - perkin transactions 1
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully treated with combination immunosuppressive therapy.
| Reference Key |
bhandari2016indiancomplete
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;D Bhandari;K D Jhaveri;H H Shah |
| Journal | journal of the chemical society - perkin transactions 1 |
| Year | 2016 |
| DOI |
10.4103/0971-4065.175985
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.